Figure 3
Kaplan-Meier survival curve for OS among 12 patients with positive EBV serum DNA at inclusion in whom EBV serum DNA became undetectable after the first cycle of the AspaMetDex regimen (n = 5) or not (n = 7).
Kaplan-Meier survival curve for OS among 12 patients with positive EBV serum DNA at inclusion in whom EBV serum DNA became undetectable after the first cycle of the AspaMetDex regimen (n = 5) or not (n = 7).
